Back
Outlook Therapeutics, Inc. 10K Form
Sell
16
OTLK
Outlook Therapeutics, Inc.
Last Price:
$0.54
Seasonality Move:
16.28%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive OTLK News And Ratings
See the #1 stock for the next 7 days that we like better than OTLK
OTLK Financial Statistics
Sales & Book Value
| Annual Sales: | $1.4M |
|---|---|
| Cash Flow: | $-11.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.86 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -0.57000 |
|---|---|
| Net Income (TTM): | $-43.4M |
| Gross Margin: | $657.2K |
| Return on Equity: | 0% |
| Return on Assets: | -161.63% |
Outlook Therapeutics, Inc. Earnings Forecast
Key Outlook Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 12 years for OTLK is 46.49%.
-
The Selling, General & Administrative Expenses for OTLK have been equal to 2,825.48% of Gross Profit Margin.
-
The Research & Development expenses have been 1,965.38% of Revenue.
-
The Net Earning history of OTLK is -4,416.34% of Total Revenues.
-
Per Share Earnings over the last 12 years have been positive in 8 years.
Outlook Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | OTLK |
| CUSIP: | 69012T |
| Website: | outlooktherapeutics.com |
Debt
| Debt-to-Equity Ratio: | -0.93 |
|---|---|
| Current Ratio: | 0.67 |
| Quick Ratio: | 0.34 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
OTLK Technical Analysis vs Fundamental Analysis
Sell
16
Outlook Therapeutics, Inc. (OTLK)
is a Sell
Is Outlook Therapeutics, Inc. a Buy or a Sell?
-
Outlook Therapeutics, Inc. stock is rated a SellThe current Outlook Therapeutics, Inc. [OTLK] share price is $0.55. The Score for OTLK is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.